Update on SARS research and other possibly zoonotic coronaviruses
Identifieur interne : 002910 ( Main/Exploration ); précédent : 002909; suivant : 002911Update on SARS research and other possibly zoonotic coronaviruses
Auteurs : Larry J. Anderson [États-Unis] ; SUXIANG TONG [États-Unis]Source :
- International journal of antimicrobial agents : (Print) [ 0924-8579 ] ; 2010.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (usage thérapeutique), Contrôle des maladies contagieuses (), Humains, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (traitement médicamenteux), Syndrome respiratoire aigu sévère (virologie), Syndrome respiratoire aigu sévère (épidémiologie), Vaccins antiviraux (immunologie), Virus du SRAS (immunologie), Virus du SRAS (pathogénicité), Zoonoses (virologie), Zoonoses (épidémiologie).
- MESH :
- immunologie : Vaccins antiviraux, Virus du SRAS.
- pathogénicité : Virus du SRAS.
- traitement médicamenteux : Syndrome respiratoire aigu sévère.
- usage thérapeutique : Antiviraux.
- virologie : Syndrome respiratoire aigu sévère, Zoonoses.
- épidémiologie : Syndrome respiratoire aigu sévère, Zoonoses.
- Pascal (Inist)
- Wicri :
- topic : Recherche, Zoonose, Santé publique.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (therapeutic use), Communicable Disease Control (methods), Coronavirus, Epidemiology, Etiopathogenesis, Humans, Molecular biology, Pathogenesis, Public health, Research, SARS Virus (immunology), SARS Virus (pathogenicity), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (prevention & control), Severe Acute Respiratory Syndrome (virology), Severe acute respiratory syndrome, Structure activity relation, Updating, Viral Vaccines (immunology), Zoonoses (epidemiology), Zoonoses (virology), Zoonosis.
- MESH :
- chemical , immunology : Viral Vaccines.
- chemical , therapeutic use : Antiviral Agents.
- drug therapy : Severe Acute Respiratory Syndrome.
- epidemiology : Severe Acute Respiratory Syndrome, Zoonoses.
- immunology : SARS Virus.
- methods : Communicable Disease Control.
- pathogenicity : SARS Virus.
- prevention & control : Severe Acute Respiratory Syndrome.
- virology : Severe Acute Respiratory Syndrome, Zoonoses.
- Animals, Humans.
Abstract
The global outbreak of severe acute respiratory syndrome (SARS) in 2003 led to an intense and effective global response that stopped the spread of the disease by July 2003. There was also an intensive and very productive research effort to identify the aetiological agent, characterise the clinical and epidemiological features of the disease, understand the pathogenesis of the disease and the molecular biology of the virus, and design antiviral drugs and vaccines to treat and prevent the disease. In parallel with the SARS research effort there have been continuous improvements in our ability to detect and characterise other novel viruses. The SARS outbreak illustrates the importance of such detection tools in the response to public health threats. Studies since the SARS outbreak suggest that many novel viruses exist in animals and some, but probably not many, will present a risk to humans.
Url:
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000121
- to stream PascalFrancis, to step Curation: 000867
- to stream PascalFrancis, to step Checkpoint: 000118
- to stream Main, to step Merge: 002950
- to stream Pmc, to step Corpus: 001070
- to stream Pmc, to step Curation: 001070
- to stream Pmc, to step Checkpoint: 000B73
- to stream PubMed, to step Corpus: 001639
- to stream PubMed, to step Curation: 001639
- to stream PubMed, to step Checkpoint: 001559
- to stream Ncbi, to step Merge: 002201
- to stream Ncbi, to step Curation: 002201
- to stream Ncbi, to step Checkpoint: 002201
- to stream Main, to step Merge: 002443
- to stream Main, to step Curation: 002910
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Update on SARS research and other possibly zoonotic coronaviruses</title><author><name sortKey="Anderson, Larry J" sort="Anderson, Larry J" uniqKey="Anderson L" first="Larry J." last="Anderson">Larry J. Anderson</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, MS A34, 1600 Clifton Rd</s1><s2>Atlanta, GA 30333</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Suxiang Tong" sort="Suxiang Tong" uniqKey="Suxiang Tong" last="Suxiang Tong">SUXIANG TONG</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, MS A34, 1600 Clifton Rd</s1><s2>Atlanta, GA 30333</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">11-0054318</idno><date when="2010">2010</date><idno type="stanalyst">PASCAL 11-0054318 INIST</idno><idno type="RBID">Pascal:11-0054318</idno><idno type="wicri:Area/PascalFrancis/Corpus">000121</idno><idno type="wicri:Area/PascalFrancis/Curation">000867</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000118</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000118</idno><idno type="wicri:doubleKey">0924-8579:2010:Anderson L:update:on:sars</idno><idno type="wicri:Area/Main/Merge">002950</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126933</idno><idno type="RBID">PMC:7126933</idno><idno type="wicri:Area/Pmc/Corpus">001070</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001070</idno><idno type="wicri:Area/Pmc/Curation">001070</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001070</idno><idno type="wicri:Area/Pmc/Checkpoint">000B73</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000B73</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:20801001</idno><idno type="wicri:Area/PubMed/Corpus">001639</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001639</idno><idno type="wicri:Area/PubMed/Curation">001639</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001639</idno><idno type="wicri:Area/PubMed/Checkpoint">001559</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001559</idno><idno type="wicri:Area/Ncbi/Merge">002201</idno><idno type="wicri:Area/Ncbi/Curation">002201</idno><idno type="wicri:Area/Ncbi/Checkpoint">002201</idno><idno type="wicri:doubleKey">0924-8579:2010:Anderson L:update:on:sars</idno><idno type="wicri:Area/Main/Merge">002443</idno><idno type="wicri:Area/Main/Curation">002910</idno><idno type="wicri:Area/Main/Exploration">002910</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Update on SARS research and other possibly zoonotic coronaviruses</title><author><name sortKey="Anderson, Larry J" sort="Anderson, Larry J" uniqKey="Anderson L" first="Larry J." last="Anderson">Larry J. Anderson</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, MS A34, 1600 Clifton Rd</s1><s2>Atlanta, GA 30333</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Suxiang Tong" sort="Suxiang Tong" uniqKey="Suxiang Tong" last="Suxiang Tong">SUXIANG TONG</name><affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, MS A34, 1600 Clifton Rd</s1><s2>Atlanta, GA 30333</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author></analytic><series><title level="j" type="main">International journal of antimicrobial agents : (Print)</title><title level="j" type="abbreviated">Int. j. antimicrob. agents : (Print)</title><idno type="ISSN">0924-8579</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">International journal of antimicrobial agents : (Print)</title><title level="j" type="abbreviated">Int. j. antimicrob. agents : (Print)</title><idno type="ISSN">0924-8579</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (therapeutic use)</term><term>Communicable Disease Control (methods)</term><term>Coronavirus</term><term>Epidemiology</term><term>Etiopathogenesis</term><term>Humans</term><term>Molecular biology</term><term>Pathogenesis</term><term>Public health</term><term>Research</term><term>SARS Virus (immunology)</term><term>SARS Virus (pathogenicity)</term><term>Severe Acute Respiratory Syndrome (drug therapy)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Severe acute respiratory syndrome</term><term>Structure activity relation</term><term>Updating</term><term>Viral Vaccines (immunology)</term><term>Zoonoses (epidemiology)</term><term>Zoonoses (virology)</term><term>Zoonosis</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (usage thérapeutique)</term><term>Contrôle des maladies contagieuses ()</term><term>Humains</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Vaccins antiviraux (immunologie)</term><term>Virus du SRAS (immunologie)</term><term>Virus du SRAS (pathogénicité)</term><term>Zoonoses (virologie)</term><term>Zoonoses (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antiviraux</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term><term>Zoonoses</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Animaux</term><term>Contrôle des maladies contagieuses</term><term>Humains</term><term>Mise à jour</term><term>Relation structure activité</term><term>Syndrome respiratoire aigu sévère</term><term>Recherche</term><term>Zoonose</term><term>Coronavirus</term><term>Pathogénie</term><term>Santé publique</term><term>Etiopathogénie</term><term>Epidémiologie</term><term>Biologie moléculaire</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Recherche</term><term>Zoonose</term><term>Santé publique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The global outbreak of severe acute respiratory syndrome (SARS) in 2003 led to an intense and effective global response that stopped the spread of the disease by July 2003. There was also an intensive and very productive research effort to identify the aetiological agent, characterise the clinical and epidemiological features of the disease, understand the pathogenesis of the disease and the molecular biology of the virus, and design antiviral drugs and vaccines to treat and prevent the disease. In parallel with the SARS research effort there have been continuous improvements in our ability to detect and characterise other novel viruses. The SARS outbreak illustrates the importance of such detection tools in the response to public health threats. Studies since the SARS outbreak suggest that many novel viruses exist in animals and some, but probably not many, will present a risk to humans.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li></region></list><tree><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Anderson, Larry J" sort="Anderson, Larry J" uniqKey="Anderson L" first="Larry J." last="Anderson">Larry J. Anderson</name></region><name sortKey="Suxiang Tong" sort="Suxiang Tong" uniqKey="Suxiang Tong" last="Suxiang Tong">SUXIANG TONG</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002910 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002910 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:11-0054318
|texte= Update on SARS research and other possibly zoonotic coronaviruses
}}
| This area was generated with Dilib version V0.6.33. |  |